Letter to the Editor
|
Open Access
Featured
-
-
Genetics and Genomics
| Open AccessMutSβ exceeds MutSα in dinucleotide loop repair
- J Kantelinen
- , M Kansikas
- & M Nyström
-
Translational Therapeutics
| Open AccessActivating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
- G Smith
- , R Bounds
- & C R Wolf
-
Molecular Diagnostics
| Open AccessFactors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer
- Y Hamaya
- , K Yoshida
- & S Kanaoka
-
Molecular Diagnostics
| Open AccessHigh expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
- E L Wang
- , Z R Qian
- & T Sano
-
Molecular Diagnostics
| Open AccessEarly growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells
- D Mahalingam
- , A Natoni
- & E Szegezdi
-
Clinical Study
| Open AccessDefining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status
- D J Watkins
- , I Chau
- & A Gillbanks
-
Genetics and Genomics
| Open AccessGene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases
- T Ishiguro
- , H Avila
- & D D Boyd
-
Genetics and Genomics
| Open AccessReversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor
- O Galamb
- , S Spisák
- & B Molnár
-
Clinical Study
| Open AccessPhase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
- T Trarbach
- , M Moehler
- & S Kanzler
-
Translational Therapeutics
| Open AccessC20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer
- K Yamaguchi
- , M Sakai
- & Y Furukawa
-
Clinical Study
| Open AccessPerformance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study
- G Tranø
- , W Sjursen
- & L J Vatten